Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target

被引:22
作者
Alatrash, G. [1 ]
Garber, H. R. [1 ]
Zhang, M. [1 ]
Sukhumalchandra, P. [1 ]
Qiu, Y. [2 ]
Jakher, H. [1 ]
Perakis, A. A. [1 ]
Becker, L. [1 ]
Yoo, S. Y. [3 ]
Dwyer, K. C. [1 ]
Coombes, K. [4 ]
Talukder, A. H. [5 ]
St John, L. S. [1 ]
Senyukov, V. [6 ]
Lee, D. A. [6 ]
Sergeeva, A. [1 ]
He, H. [1 ]
Ma, Q. [1 ]
Armistead, P. M. [7 ]
Roszik, J. [5 ,8 ]
Mittendorf, E. A. [9 ]
Molldrem, J. J. [1 ]
Hawke, D. [10 ]
Lizee, G.
Kornblau, S. M. [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Sect Transplant Immunol, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[3] MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX USA
[4] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA
[5] MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX USA
[6] MD Anderson Canc Ctr, Dept Pediat, Houston, TX USA
[7] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[8] MD Anderson Canc Ctr, Dept Genom Med, Houston, TX USA
[9] MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX USA
[10] MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX USA
基金
美国国家卫生研究院;
关键词
HIPPO PATHWAY; AML; MUTATIONS; CELLS;
D O I
10.1038/leu.2016.249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:234 / 237
页数:4
相关论文
共 15 条
  • [1] Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype
    Bacher, U.
    Haferlach, T.
    Alpermann, T.
    Kern, W.
    Schnittger, S.
    Haferlach, C.
    [J]. LEUKEMIA, 2013, 27 (02) : 496 - 500
  • [2] Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML
    Carter, Bing Z.
    Qiu, Yi Hua
    Zhang, Nianxiang
    Coombes, Kevin R.
    Mak, Duncan H.
    Thomas, Deborah A.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Koller, Erich
    Andreeff, Michael
    Kornblau, Steven M.
    [J]. BLOOD, 2011, 117 (03) : 780 - 787
  • [3] Hematopoietic stem cell transplantation for patients with AML in first complete remission
    Cornelissen, Jan J.
    Blaise, Didier
    [J]. BLOOD, 2016, 127 (01) : 62 - 70
  • [4] An update of current treatments for adult acute myeloid leukemia
    Dombret, Herve
    Gardin, Claude
    [J]. BLOOD, 2016, 127 (01) : 53 - 61
  • [5] In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins
    Fujiwara, H
    Melenhorst, JJ
    El Ouriaghli, F
    Kajigaya, S
    Grube, M
    Sconocchia, G
    Rezvani, K
    Price, DA
    Hensel, NF
    Douek, DC
    Barrett, AJ
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (12) : 4495 - 4503
  • [6] Garwicz D, 2005, HAEMATOLOGICA, V90, P38
  • [7] Surface plasmon resonance imaging biosensor for cathepsin G based on a potent inhibitor: Development and applications
    Gorodkiewicz, Ewa
    Sienczyk, Marcin
    Regulska, Elzbieta
    Grzywa, Renata
    Pietrusewicz, Ewa
    Lesner, Adam
    Lukaszewski, Zenon
    [J]. ANALYTICAL BIOCHEMISTRY, 2012, 423 (02) : 218 - 223
  • [8] Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells
    Hosen, N
    Sonoda, Y
    Oji, Y
    Kimura, T
    Minamiguchi, H
    Tamaki, H
    Kawakami, M
    Asada, M
    Kanato, K
    Motomura, M
    Murakami, M
    Fujioka, T
    Masuda, T
    Kim, EH
    Tsuboi, A
    Oka, Y
    Soma, T
    Ogawa, H
    Sugiyama, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) : 409 - 420
  • [9] Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12)(q22;p13) in acute myeloid leukemia
    Ogawa, Shinichi
    Yokoyama, Yasuhisa
    Suzukawa, Kazumi
    Nanmoku, Toru
    Kurita, Naoki
    Seki, Masanori
    Maie, Koichiro
    Suyama, Takuya
    Takaiwa, Naoko
    Sakata-Yanagimoto, Mamiko
    Obara, Naoshi
    Hasegawa, Yuichi
    Chiba, Shigeru
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (08) : 1431 - 1433
  • [10] Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo
    Sergeeva, A.
    He, H.
    Ruisaard, K.
    St John, L.
    Alatrash, G.
    Clise-Dwyer, K.
    Li, D.
    Patenia, R.
    Hong, R.
    Sukhumalchandra, P.
    You, M. J.
    Gagea, M.
    Ma, Q.
    Molldrem, J. J.
    [J]. LEUKEMIA, 2016, 30 (07) : 1475 - 1484